CNBC - Health
Trump says he's 'concerned' about Ebola after American tests positive in Africa
8 hours ago
White House adds generic drugs to direct-to-consumer TrumpRx site9 hours ago
CDC says American tests positive for Ebola in Africa, risk in U.S. remains low9 hours ago
FDA shuffles top drug, biologics leaders in latest leadership shakeup3 days ago
Bristol Myers Squibb turns to China to develop new drugs3 days ago
CDC says there are no U.S. hantavirus cases currently, 41 people being monitored4 days ago
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data4 days ago
Hantavirus isn't another Covid, but experts say it's testing U.S. readiness4 days ago
Trump says Makary resigns as FDA commissioner following backlash4 days ago
Novo Nordisk: High-dose Wegovy caused nearly 28% weight loss in some patients6 days ago
Jim Cramer says today's market is punishing stocks harder than 19997 days ago
Hantavirus cases spark brief surge in pharma and biotech stocks — here's why trading is so volatile7 days ago
Cruise ship hantavirus outbreak: An expedition boom and new world of travel risk7 days ago
Fitness wearable Whoop to offer on-demand clinician access to U.S. users10 days ago
Healthy Returns: Novo Nordisk faces Ozempic generics in Canada10 days ago
Planet Fitness stock plunges 30% after company slashes guidance11 days ago
Family office deal-making rebounds in April with healthcare bets11 days ago
Rare disease families find roadmap to drug development at bootcamps11 days ago
Novo Nordisk CEO says the drugmaker is more active than ever for dealmaking11 days ago
Wearable patches: How Barrière is trying to disrupt the supplement industry12 days ago
CVS blows past estimates, hikes outlook as insurance business outperforms12 days ago
FDA withdrew studies finding Covid and shingles vaccines were safe12 days ago
FDA commissioner defends agency's drug approval decisions after wave of backlash13 days ago
Major health insurers show early strength – but a key test looms in Q213 days ago
Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth13 days ago
Novo's head start on GLP-1 pills forces investors to rethink Lilly's dominance13 days ago
Weight loss and hair loss: The growing hair treatment market from GLP-1s16 days ago
Cardinal Health's sell-off on earnings was an overreaction. We'd be buyers17 days ago
Trump picks Nicole Saphier for surgeon general after pulling Casey Means17 days ago
Eli Lilly shares surge on a beat-and-raise, proving the stock's swoon was a mistake18 days ago
FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list18 days ago
More than 20,000 people are taking Eli Lilly's weight loss pill Foundayo, CEO says18 days ago
